MDBH

4 - MDB Capital Holdings, LLC (0001934642) (Issuer)

4 - MDB Capital Holdings, LLC (0001934642) (Issuer)

4 - MDB Capital Holdings, LLC (0001934642) (Issuer)

DALLAS, TX, Oct. 21, 2026 (GLOBE NEWSWIRE) -- PatentVest, an AI-enabled intellectual property law firm, announces the publication of a new article, "Invention Provenance: Why the Verifiable Origin of an Invention Now Decides Who Owns It," by Will Rosellini, Chief IP Officer at PatentVest. The article examines how generative AI, distributed research and development teams, and increasingly complex collaboration models are changing the way companies establish inventorship, document contributions, and protect patent ownership. As AI becomes more deeply integrated into the innovation process, companies face a growing challenge: demonstrating who contributed to an invention, how those contribu

4 - MDB Capital Holdings, LLC (0001934642) (Issuer)

4 - MDB Capital Holdings, LLC (0001934642) (Issuer)

4 - MDB Capital Holdings, LLC (0001934642) (Issuer)

DALLAS, Texas, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Bio North Texas (BioNTX) and PatentVest today announced a new multi-year strategic partnership designed to strengthen the innovation and commercialization ecosystem supporting emerging life science and healthcare companies across North Texas. As part of the collaboration, PatentVest will work alongside BioNTX to enhance the organization’s nationally recognized Rising Stars program by introducing an intellectual property diligence framework that provides founders, investors, and judges with additional insight into one of the most important assets of an emerging life science company, its intellectual property. The partnership reflects a sha

Dallas,TX, Aug. 27, 2026 (GLOBE NEWSWIRE) -- PatentVest, a provider of patent-based competitive intelligence for technology, IP, and innovation leaders, today released its newest PV Pulse report, "Who's Actually Building the AI in AI Smart Glasses?" The report analyzes validated patent activity across 12 companies shaping the category — the seven companies currently building or shipping AI smart glasses, two component suppliers whose IP sits underneath nearly every product in the space, and three large technology companies with no shipping product at all. The analysis finds that two of those three non-shipping companies, Apple and Microsoft, hold some of the strongest AI-capability patent

10-Q - MDB Capital Holdings, LLC (0001934642) (Filer)

Addison, TX, Aug. 13, 2026 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ:MDBH) ("MDB"), a public venture platform focused on launching category-defining, disruptive technology companies, provides a business update for the quarter ended June 30, 2026, and subsequent developments. First Six Months of 2026 and Subsequent Operational Highlights Completed $20 million IPO for Buda Juice (NYSE:BUDA) as the sole bookrunner and underwriter, our 18th consecutive successful IPO. Partnered with Roth Capital Partners and Bancroft Capital as joint bookrunners for the $15 million Ticketplus IPO (NYSE American; TP).Completed underwriting of $5.9 million public offering for eXoZymes (NASDAQ:EXO

Addison, TX, July 30, 2026 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ:MDBH) ("MDB"), a public venture platform focused on launching category-defining, disruptive technology companies, will host a Zoom webinar on Thursday, August 13, 2026 at 4:30 p.m. Eastern Time to provide an operational update for the quarter ended June 30, 2026, and subsequent developments. A press release detailing the updates will be issued prior to the call. Christopher Marlett, CEO and Co-Founder of MDB will lead the call and may be joined by other members of the management team to review recent developments and ongoing initiatives as well as host a question-and-answer period. Investors can pre-registe

DALLAS, Texas, July 23, 2026 (GLOBE NEWSWIRE) -- PatentVest, the first fully integrated IP intelligence, strategy, and law firm, today released its latest PatentVest Pulse, an in-depth analysis of OpenAI's published patent portfolio and intellectual property strategy. Titled "What Is OpenAI Actually Patenting?", the report examines how OpenAI's patent activity aligns with its expanding AI product ecosystem and long-term competitive positioning. Generative AI is rapidly evolving beyond conversational interfaces into intelligent systems capable of creating media, writing and executing code, operating software, coordinating workflows, and supporting persistent digital work. OpenAI has played

Dallas, TX, July 02, 2026 (GLOBE NEWSWIRE) -- PatentVest today announced the publication of a new article in its IP Legal Insights section, continuing the firm's commitment to providing practical legal guidance on the technologies and legal developments reshaping intellectual property. The latest article, "Why Patent Prosecution Is Ready for AI," written by Michael Ohrenberger, Patent Attorney at PatentVest, explores why patent prosecution is uniquely positioned to benefit from artificial intelligence. As AI rapidly transforms legal services, the article explains why patent prosecution, with its structured workflows, standardized processes, and extensive technical datasets, is one of the

The new PatentVest Pulse report examines how FGF21 is emerging as the next strategic cardiometabolic layer beyond GLP-1, reshaping obesity therapeutics, pharmaceutical partnerships, and intellectual property strategyThe report analyzes more than $10.7 billion in recent acquisitions and licensing activity, highlighting how leading pharmaceutical companies are positioning themselves for the next phase of obesity innovation Dallas, TX, June 30, 2026 (GLOBE NEWSWIRE) -- Today, PatentVest, a leading provider of IP Strategy and IP Law services, announced the release of its latest PatentVest Pulse report, "The Crossover: How FGF21 Became the Cardiometabolic Layer Beneath GLP-1." The report expl

Dallas, TX, June 15, 2026 (GLOBE NEWSWIRE) -- PatentVest, the first integrated IP intelligence, strategy, and law firm built for companies where patents drive enterprise value, announced today that it will be present at Planet MicroCap Las Vegas on June 17 at 11:30 AM PT. PatentVest combines experienced intellectual property counsel, dedicated analysts, and proprietary technology to help innovation-driven companies build stronger patent portfolios, make better strategic decisions, and maximize the value of intellectual property assets. The firm's services include intellectual property strategy, patent portfolio analysis, competitive intelligence, patentability assessments, diligence supp

• Analysis of 20 muscle-preservation programs highlights a rapidly emerging category designed to enhance long-term obesity treatment outcomes • PatentVest's report reveals how combination therapy IP, body-composition optimization, and strategic acquisitions may shape the next phase of obesity therapeutics Dallas, Texas, June 04, 2026 (GLOBE NEWSWIRE) -- Today, PatentVest, a leading provider of IP Strategy and IP Law services, announces the release of its latest report, "The Muscle Problem: How Myostatin Could Expand the GLP-1 Opportunity" This comprehensive study provides a strategic analysis of the emerging muscle-preservation category developing alongside obesity therapies. The releas

Addison, Texas, June 03, 2026 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC (NASDAQ:MDBH) today announced that its CEO & Co-Founder, Chris Marlett, will present live at the Planet MicroCap Las Vegas 2026 conference on Wednesday, June 17, 2026 at 2:00 p.m. ET / 11:00 a.m. PT at the Bellagio Resort & Hotel in Las Vegas, Nevada. Marlett will provide an overview of MDB's unique public venture capital model built to provide rational capital for founders of early-stage, category defining companies and asymmetric upside with public market liquidity for investors. Live Webcast: Watch Chris Marlett Presentation. Additionally, PatentVest, MDB's wholly-owned subsidiary and the first integrated IP

· New case study highlights how PatentVest helped Docana navigate a complex AI patent landscape through freedom-to-operate analysis, competitive intelligence, and strategic IP positioning. · The launch introduces a new Case Studies section on the PatentVest website focused on real-world examples of strategic IP leadership and innovation management. Dallas, TX, May 19, 2026 (GLOBE NEWSWIRE) -- Today, PatentVest, a leading provider of IP Strategy and IP Law services, announced the launch of a new Case Studies section on its website, beginning with a featured engagement with Docana, an artificial intelligence company operating within a rapidly evolving LLM-related patent environment. The c

10-Q - MDB Capital Holdings, LLC (0001934642) (Filer)

4 - MDB Capital Holdings, LLC (0001934642) (Issuer)

4 - MDB Capital Holdings, LLC (0001934642) (Issuer)

3 - MDB Capital Holdings, LLC (0001934642) (Issuer)

· Analysis of 27 global triple-agonist programs highlights a rapidly expanding pipeline across major pharmaceutical companies and emerging biotech platforms. · PatentVest's report reveals how intellectual property strategy, receptor-ratio engineering, and delivery platforms may determine the next leaders in obesity therapeutics. DALLAS, TX, May 08, 2026 (GLOBE NEWSWIRE) -- Today, PatentVest, a leading provider of IP Strategy and IP Law services, announces the release of its latest report, "The Triple-Agonist Race: Retatrutide, Twenty-Seven Programs, and the Hidden Patent War Behind the Next Obesity Market." This comprehensive study provides a strategic analysis of the rapidly evolving ob

4 - MDB Capital Holdings, LLC (0001934642) (Issuer)